1. Home
  2. MDXH vs AIRG Comparison

MDXH vs AIRG Comparison

Compare MDXH & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • AIRG
  • Stock Information
  • Founded
  • MDXH 2003
  • AIRG 1995
  • Country
  • MDXH Belgium
  • AIRG United States
  • Employees
  • MDXH N/A
  • AIRG N/A
  • Industry
  • MDXH
  • AIRG Radio And Television Broadcasting And Communications Equipment
  • Sector
  • MDXH
  • AIRG Technology
  • Exchange
  • MDXH Nasdaq
  • AIRG Nasdaq
  • Market Cap
  • MDXH 93.1M
  • AIRG 107.7M
  • IPO Year
  • MDXH 2021
  • AIRG 2016
  • Fundamental
  • Price
  • MDXH $2.37
  • AIRG $7.51
  • Analyst Decision
  • MDXH Strong Buy
  • AIRG Strong Buy
  • Analyst Count
  • MDXH 2
  • AIRG 2
  • Target Price
  • MDXH $7.00
  • AIRG $11.75
  • AVG Volume (30 Days)
  • MDXH 162.3K
  • AIRG 34.6K
  • Earning Date
  • MDXH 11-06-2024
  • AIRG 11-12-2024
  • Dividend Yield
  • MDXH N/A
  • AIRG N/A
  • EPS Growth
  • MDXH N/A
  • AIRG N/A
  • EPS
  • MDXH N/A
  • AIRG N/A
  • Revenue
  • MDXH $84,708,000.00
  • AIRG $55,586,000.00
  • Revenue This Year
  • MDXH $27.57
  • AIRG $14.12
  • Revenue Next Year
  • MDXH $20.09
  • AIRG $15.47
  • P/E Ratio
  • MDXH N/A
  • AIRG N/A
  • Revenue Growth
  • MDXH 33.01
  • AIRG N/A
  • 52 Week Low
  • MDXH $1.55
  • AIRG $3.06
  • 52 Week High
  • MDXH $4.64
  • AIRG $10.34
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 65.97
  • AIRG 27.36
  • Support Level
  • MDXH $2.34
  • AIRG $7.88
  • Resistance Level
  • MDXH $2.52
  • AIRG $9.12
  • Average True Range (ATR)
  • MDXH 0.14
  • AIRG 0.36
  • MACD
  • MDXH 0.05
  • AIRG -0.13
  • Stochastic Oscillator
  • MDXH 77.61
  • AIRG 5.74

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

Share on Social Networks: